| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net revenue | 820,314 | 800,372 | 777,882 | 805,858 |
| Cost of net revenue | 658,372 | 645,714 | 657,444 | 681,866 |
| General and administrative expenses | 90,111 | 97,436 | 86,854 | 49,242 |
| Depreciation and amortization, excluding patient equipment depreciation | 10,101 | 10,195 | 10,414 | 11,263 |
| Goodwill impairment (note 7) | 0 | 0 | - | - |
| Total costs and expenses | 758,584 | 753,345 | 754,712 | 742,371 |
| Gain on sale of businesses | 0 | 32,225 | - | - |
| Operating income | 61,730 | 79,252 | 23,170 | 63,487 |
| Interest expense, net | -25,380 | -27,533 | -28,399 | 31,429 |
| Loss on extinguishment of debt | 0 | - | - | -2,273 |
| Change in fair value of warrant liability (note 12) | 0 | 0 | - | -2,243 |
| Other loss | 0 | 0 | - | - |
| Income before income taxes | 36,350 | 51,719 | -5,229 | 32,028 |
| Income tax expense (benefit) | 10,600 | 35,891 | 850 | 8,073 |
| Net income | 25,750 | 15,828 | -6,079 | 23,955 |
| Income attributable to noncontrolling interest | 1,241 | 1,154 | 1,128 | 1,096 |
| Net income attributable to adapthealth corp | 24,509 | 14,674 | -7,207 | 22,859 |
| Basic net income per share (in dollars per share) | 0.17 | 0.1 | -0.05 | 0.16 |
| Diluted net income per share (in dollars per share) | 0.16 | 0.1 | -0.05 | 0.15 |
| Weighted average common shares outstanding - basic (in shares) | 135,345,000 | 134,993,000 | 134,799,000 | 134,303,000 |
| Weighted average common shares outstanding - diluted (in shares) | 137,211,000 | 137,071,000 | 134,799,000 | 136,530,000 |
AdaptHealth Corp. (AHCO)
AdaptHealth Corp. (AHCO)